Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...

Their study, published in Molecular Psychiatry, describes where and what receptor ketamine binds to in the brain to provide its anti-depressant effects in as little as a few hours. The research ...

Published in Molecular Psychiatry ... simulated the three-dimensional structure of the NMDA receptor and predicted the exact ...